Ustekinumab analyses support safety for longer-term treatment, efficacy in ... ModernMedicine Seoul, South Korea — Findings from a recent pooled analysis including collection from patients with degenerative plaque psoriasis receiving ustekinumab (Stelara, Janssen Biotech) for up to four age show that rates of adverse events associated with this ... Link To Article
No comments:
Post a Comment